5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Distal Renal Tubular Acidosis in Sjögren's Syndrome: A Case Report

      case-report
      1 , , 2 , 2
      ,
      Cureus
      Cureus
      sjögren’s syndrome, renal tubular acidosis, hypokalemic paralysis

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sjögren’s syndrome is an autoimmune lymphocytic infiltrative disease that leads to chronic inflammatory and degradatory changes to exocrine glands and extra-glandular systemic organs. It rarely affects children and adolescents. In cases where adolescents are affected, a paucity of sicca symptoms, xerostomia, and xerophthalmia often leads to a missed diagnosis. Consequently, the first presenting sign of Sjögren’s syndrome in adolescents may be heterogeneous, with varying clinical symptoms related to parotitis or systemic organ involvement. In this case report, we discuss a 19-year-old girl with distal renal tubular acidosis (RTA), who had experienced severe hypokalemic episodes since the age of 14 years; the patient was eventually diagnosed with Sjögren’s syndrome. She was managed and maintained on potassium and alkali repletion therapy.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: not found

          Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

          C Vitali (2002)
          Classification criteria for Sjögren's syndrome (SS) were developed and validated between 1989 and 1996 by the European Study Group on Classification Criteria for SS, and broadly accepted. These have been re-examined by consensus group members, who have introduced some modifications, more clearly defined the rules for classifying patients with primary or secondary SS, and provided more precise exclusion criteria.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of Primary Sjögren's Syndrome in a US Population-Based Cohort

            Objective To report the point prevalence of primary Sjögren’s syndrome (pSS) in the first population-based study performed in the United States. Methods Cases of all potential pSS patients living in Olmsted County, Minnesota on January 1, 2015 were retrieved using the Rochester Epidemiology Project resources, and ascertained by manual medical record review. pSS cases were defined according to physician diagnosis. The use of diagnostic tests was assessed and the performance of classification criteria was evaluated. The number of prevalent cases in 2015 was also projected based on 1976–2005 incidence data from the same source population. Results A total of 106 patients with pSS were included in the study: 86% were female, with a mean (SD) age of 64.6 (15.2) years and disease duration of 10.5 (8.4) years. A majority were anti-SSA positive (75%) and/or anti-SSB positive (58%), but only 22% met American-European Consensus Group or American College of Rheumatology criteria because the other tests required for disease classification were rarely performed in clinical practice (ocular dryness objective assessment, salivary gland functional or morphologic tests, or salivary gland biopsy). According to the physician diagnosis, age and sex adjusted prevalence of pSS was 10.3/10,000 inhabitants, but according to classification criteria this prevalence was only 2.2/10,000. The analysis based on previous incidence data projected a similar 2015 prevalence rate of 11.0/10,000. Conclusion The prevalence of pSS in this geographically well-defined population was estimated between 2 and 10/10,000 inhabitants. Physicians rarely used tests included in the classification criteria to diagnose the disease in this community setting.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.

              Anti-Ro/SSA antibodies, which were described for the first time in systemic lupus erythematosus (SLE) and Sjögren's syndrome (SS), are the most prevalent extractable nuclear antigen (ENA) specificity identified in laboratories. Two types of anti-Ro/SSA antibodies have been described, anti-SSA-52 kDa (aSSA52) and anti-SSA-60 kDa (aSSA60), each specific to different antigens. Anti-Ro/SSA52 autoantibodies are more frequent than other autoantibodies possibly because of the antigen's accessible and ubiquitous nature. The sites involved and the symptoms associated with these autoantibodies depend on the antigen's structural variability. Isolated congenital complete atrioventricular block (CAVB) shows a close association with maternal anti-Ro/SSA and anti-La/SSB antibodies; the highest relative risks of CAVB are seen in offspring of mothers with antibodies against 52-kDa Ro and 48-kDa La proteins. Anti-Ro/SSA52 antibodies have little impact on adult rheumatic autoimmune diseases or adult cardiac arrhythmias, but the course of autoimmune liver diseases is greatly worsened by their presence, and solid tumours tend to relapse. Their diagnostic role in rheumatic diseases is controversial, although a significant association between isolated anti-Ro/SSA52-kDa positivity and myositis and to a lesser extent with systemic sclerosis (SSc) has been described. However, the majority of the specific diagnosis is mostly based on the simultaneous presence of other autoantibodies that seems diagnostically more relevant. Copyright © 2010 Elsevier B.V. All rights reserved.
                Bookmark

                Author and article information

                Journal
                Cureus
                Cureus
                2168-8184
                Cureus
                Cureus (Palo Alto (CA) )
                2168-8184
                15 October 2020
                October 2020
                : 12
                : 10
                : e10962
                Affiliations
                [1 ] Department of Medicine, American University of Antigua, Saint John's, ATG
                [2 ] Department of Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, USA
                Author notes
                Scarlet Louis-Jean scarletl@ 123456auamed.net
                Article
                10.7759/cureus.10962
                7567320
                33083163
                1cff86ba-5410-4aa1-9301-fe42c699ac39
                Copyright © 2020, Louis-Jean et al.

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 15 October 2020
                Categories
                Internal Medicine
                Nephrology
                Rheumatology

                sjögren’s syndrome,renal tubular acidosis,hypokalemic paralysis

                Comments

                Comment on this article